Active leadership and unity for all members to thrive in the evolving hematology oncology community
Menu
About
Mission
Benefits
Board of Directors
Committees
Join
Corporate Allies
Legislative
Newsletters
Presentations
Annual Conference
Member Login
Latest News
Changes to POHMS Membership Dues for 2023!
read more >
2023 Corporate Membership
read more >
IMPORTANT NOTICE: POHMS Change of Address
read more >
Pharmacyclics: Imbruvica cGVHD approval
read more >
New Indication: ENHERTU (Daiichi Sankyo Inc)
read more >
